Vestibular function is also vulnerable

BMJ

Volumn 335, Issue 7627, 2007, Pages 952-

  Seemungal, Barry M ^a   Bronstein, Adolfo M ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; GENTAMICIN; PROCHLORPERAZINE MALEATE; ANTIINFECTIVE AGENT;

CALORIC VESTIBULAR TEST; GAIT DISORDER; HEAD MOVEMENT; HEARING IMPAIRMENT; HUMAN; LETTER; OSCILLOPSIA; OTOTOXICITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; VERTIGO; VESTIBULAR DISORDER; VESTIBULAR FUNCTION; CHEMICALLY INDUCED DISORDER; HEARING LOSS; NOTE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; HEARING LOSS; HUMANS; VESTIBULAR DISEASES;

EID: 85007711905     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.39388.451019.1F     Document Type: Letter

References (4)

1. Bitner-Glindzicz M, Rahman S. Ototoxicity caused by aminoglycosides. BMJ 2007; 335: 784-5. (20 October.)
2. Shiyama G, Ishiyama A, Kerber K, Baloh RW. Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex. Acta Otolaryngol 2006; 126: 1057-61.
3. Rinne T, Bronstein AM, Rudge P, Gresty MA, Luxon LM. Bilateral loss of vestibular function. Acta Otolaryngol 1995;(suppl 520 Pt 2):247-250.
4. Halmagyi GM, Curthoys IS. A clinical sign of canal paresis. Arch Neurol 1988; 45: 737-9.